Clinical Trial

Deep Versus Moderate Neuromuscular Blocking

Recruiting
View on ClinicalTrials.gov →
Summary
This study aimed for Determination of the impacts of deep neuromuscular blockade (DNMB) on surgical outcomes, consumption of perioperative opioid analgesia, and serum levels of inflammatory cytokines in comparison to moderate NMB (MNMB).
Protocol Amendment History 4 changes
critical Recruitment opened 2026-08-14
critical Trial status changed: Recruiting → Not Yet Recruiting 2026-06-03
notable Primary completion pushed: 2026-08-01 -> 2026-12-01 2026-06-03
minor Completion pushed: 2026-09-01 -> 2026-12-30 2026-06-03
Trial Details
NCT Number NCT07485517
Lead Sponsor Menoufia University
Conditions Change in Serum Levels of the Estimated Inflammatory Cytokines, Total Dose of IO Fentanyl, PO Morphine, Surgeons' Rating, Pain Scores
Enrollment 88 participants
Start Date 2026-06-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-13